315 related articles for article (PubMed ID: 25896830)
1. Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Radiat Oncol; 2015 Apr; 10():93. PubMed ID: 25896830
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
[TBL] [Abstract][Full Text] [Related]
3. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
[TBL] [Abstract][Full Text] [Related]
4. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?
Mekhail TM; Adelstein DJ; Rybicki LA; Larto MA; Saxton JP; Lavertu P
Cancer; 2001 May; 91(9):1785-90. PubMed ID: 11335904
[TBL] [Abstract][Full Text] [Related]
5. Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes.
Franco P; Potenza I; Schena M; Riva G; Pecorari G; Garzino Demo P; Fasolis M; Moretto F; Garzaro M; Di Muzio J; Melano M; Airoldi M; Ragona R; Rampino M; Ricardi U
Anticancer Res; 2015 Nov; 35(11):6247-54. PubMed ID: 26504058
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.
Strom T; Trotti AM; Kish J; Rao NG; McCaffrey J; Padhya TA; Lin HY; Fulp W; Caudell JJ
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1242-6. PubMed ID: 24136493
[TBL] [Abstract][Full Text] [Related]
7. Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy.
Rutter CE; Yovino S; Taylor R; Wolf J; Cullen KJ; Ord R; Athas M; Zimrin A; Strome S; Suntharalingam M
Head Neck; 2011 Oct; 33(10):1441-7. PubMed ID: 21928416
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.
Kao J; Genden EM; Gupta V; Policarpio EL; Burri RJ; Rivera M; Gurudutt V; Som PM; Teng M; Packer SH
Cancer; 2011 Jan; 117(2):318-26. PubMed ID: 20830768
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
[TBL] [Abstract][Full Text] [Related]
10. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
Bhayani MK; Hutcheson KA; Barringer DA; Roberts DB; Lewin JS; Lai SY
Head Neck; 2013 Nov; 35(11):1641-6. PubMed ID: 23322545
[TBL] [Abstract][Full Text] [Related]
11. Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone.
Poulsen MG; Riddle B; Keller J; Porceddu SV; Tripcony L
Radiother Oncol; 2008 May; 87(2):253-9. PubMed ID: 18410976
[TBL] [Abstract][Full Text] [Related]
12. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE
Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030
[TBL] [Abstract][Full Text] [Related]
13. Enteral feeding in head and neck cancer patients at a UK cancer centre.
Sheth CH; Sharp S; Walters ER
J Hum Nutr Diet; 2013 Oct; 26(5):421-8. PubMed ID: 23379517
[TBL] [Abstract][Full Text] [Related]
14. Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Spratt DE; Diaz R; Phillips JG; Crass J; Li CI; Shyr Y; Cmelak AJ
Radiother Oncol; 2014 Mar; 110(3):435-40. PubMed ID: 24440043
[TBL] [Abstract][Full Text] [Related]
15. Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.
Yang W; McNutt TR; Dudley SA; Kumar R; Starmer HM; Gourin CG; Moore JA; Evans K; Allen M; Agrawal N; Richmon JD; Chung CH; Quon H
Dysphagia; 2016 Apr; 31(2):206-13. PubMed ID: 26753929
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study.
Wiggenraad RG; Flierman L; Goossens A; Brand R; Verschuur HP; Croll GA; Moser LE; Vriesendorp R
Clin Otolaryngol; 2007 Oct; 32(5):384-90. PubMed ID: 17883560
[TBL] [Abstract][Full Text] [Related]
18. Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.
Bozec A; Benezery K; Chamorey E; Ettaiche M; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Sudaka A; Haudebourg J; Hebert C; Falewee MN; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2681-7. PubMed ID: 26395117
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
